Results 151 to 160 of about 80,326 (305)

Long‐term efficacy of adjunctive cenobamate: Open‐label extension of a randomized, placebo‐controlled study in a multinational Asian population

open access: yesEpilepsia, EarlyView.
Long‐term efficacy and safety of adjunctive cenobamate in a multinational Asian population. Open‐label extension (OLE) efficacy population included all patients who had taken ≥1 dose of study drug and had any seizure data during the OLE maintenance phase.
Sang Kun Lee   +20 more
wiley   +1 more source

Vertigo: Marcel Duchamp and Mark Titchner

open access: yes, 2007
My proposal and the methodology for this curatorial project was to invite Mark Titchner to view and handle Duchamp’s ‘Rotoreliefs’ and the ‘Rotorelief Machine’ held in the special collections of the library at Chelsea College of Art and Design in order ...
Smith, Donald
core   +1 more source

VertigO, partenaire des 10es Rencontres internationales du documentaire de Montréal (RIDM)

open access: yes, 2007
VertigO – la revue électronique en sciences de l’environnement est fière d’annoncer son partenariat avec la 10e édition des Rencontres internationales du documentaire de Montréal et tout spécialement avec son volet ÉcoCaméra.
Eric Duchemin
core  

Sustained seizure reduction, treatment simplification, and high retention with cenobamate: A 12‐month real‐world study in refractory and ultra‐refractory focal epilepsy

open access: yesEpilepsia Open, EarlyView.
Abstract Objective To assess the 12‐month clinical impact of cenobamate (CNB) in adults with drug‐resistant focal epilepsy in clinical practice, exploring whether outcomes differed according to prior antiseizure medication (ASM) exposure. Methods This single‐center, retrospective, observational, real‐world study included 91 adults stratified by the ...
Francesca Cutropia   +13 more
wiley   +1 more source

BENIGN PAROXYSMAL POSITIONAL VERTIGO: CLINICAL FEATURES AND TREATMENT

open access: yes
Benign Paroxysmal Positional Vertigo (BPPV) is a prevalent vestibular disorder usually characterized by brief vertigo episodes triggered by specific head movements.
AL KHATIB, SHADI
core  

Real‐world use of Cenobamate in pediatric drug‐resistant epilepsy: A European multicenter retrospective study

open access: yesEpilepsia Open, EarlyView.
Abstract Pediatric drug‐resistant epilepsy (DRE) remains a significant clinical challenge, with few effective pharmacological options. This European multicenter retrospective study assessed the real‐world efficacy, tolerability, and retention of off‐label cenobamate (CNB) in 108 children and adolescents with DRE (median age: 13.83 years, range 3.9–19.8)
Konstantin L. Makridis   +14 more
wiley   +1 more source

Frequency of anti‐neural antibodies and autoimmune epilepsy in focal epilepsy of unknown etiology: An observational study in a Singaporean cohort

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Autoimmune epilepsy (AES) is increasingly recognized as a condition in patients with epilepsy of unknown etiology. Early immunotherapy improves outcomes; however, data on its prevalence and the frequency of anti‐neural/neuronal antibodies in Asian populations remain scarce.
Seong Jin Park   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy